Abstract:Background: Methylation of CpG islands within the DNA promoter regions is one mechanism that leads to aberrant gene expression in cancer. In particular, the abnormal methylation of CpG islands may silence associated genes. Therefore, using high-throughput microarrays to measure CpG island methylation will lead to better understanding of tumor pathobiology and progression, while revealing potentially new biomarkers. We have examined a recently developed high-throughput technology for measuring genome-wide methylation patterns called mTACL. Here, we propose a computational pipeline for integrating gene expression and CpG island methylation profiles to identify epigenetically regulated genes for a panel of 45 breast cancer cell lines, which is widely used in the Integrative Cancer Biology Program (ICBP). The pipeline (i) reduces the dimensionality of the methylation data, (ii) associates the reduced methylation data with gene expression data, and (iii) ranks methylation-expression associations according to their epigenetic regulation. Dimensionality reduction is performed in two steps: (i) methylation sites are grouped across the genome to identify regions of interest, and (ii) methylation profiles are clustered within each region. Associations between the clustered methylation and the gene expression data sets generate candidate matches within a fixed neighborhood around each gene. Finally, the methylation-expression associations are ranked through a logistic regression, and their significance is quantified through permutation analysis. Results: Our two-step dimensionality reduction compressed 90% of the original data, reducing 137,688 methylation sites to 14,505 clusters. Methylation-expression associations produced 18,312 correspondences, which were used to further analyze epigenetic regulation. Logistic regression was used to identify 58 genes from these correspondences that showed a statistically significant negative correlation between methylation profiles and gene expression in the panel of breast cancer cell lines. Subnetwork enrichment of these genes has identified 35 common regulators with 6 or more predicted markers. In addition to identifying epigenetically regulated genes, we show evidence of differentially expressed methylation patterns between the basal and luminal subtypes. Conclusions: Our results indicate that the proposed computational protocol is a viable platform for identifying epigenetically regulated genes. Our protocol has generated a list of predictors including COL1A2, TOP2A, TFF1, and VAV3, genes whose key roles in epigenetic regulation is documented in the literature. Subnetwork enrichment of these predicted markers further suggests that epigenetic regulation of individual genes occurs in a coordinated fashion and through common regulators.

Integrated analysis of gene expression and methylation profiles of 48 candidate genes in breast cancer patients

Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients

Biomarker Discovery To Improve Prediction Of Breast Cancer Survival: Using Gene Expression Profiling, Meta-Analysis, And Tissue Validation

Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers

Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.

Methylation Profiles of 22 Candidate Genes in Breast Cancer Using High-Throughput MALDI-TOF Mass Array

Discovered Key CpG Sites by Analyzing DNA Methylation and Gene Expression in Breast Cancer Samples

Identification of Aberrantly Methylated Differentially Expressed Genes in Breast Cancer by Integrated Bioinformatics Analysis

Discovering the Key Genes and Important DNA Methylation Regions in Breast Cancer

Identification of a DNA Methylation-Driven Genes-Based Prognostic Model and Drug Targets in Breast Cancer: In silico Screening of Therapeutic Compounds and in vitro Characterization

Clinical signiifcance of BRCA1, GSTP1 and MGMT gene methylation status in breast cancer

Prediction of epigenetically regulated genes in breast cancer cell lines

Determination of Genetic and Epigenetic Modifications-Related Prognostic Biomarkers of Breast Cancer: Genome High-Throughput Data Analysis

DNA Methylation Markers for Diagnosis and Prognosis of Common Cancers.

Identification of differentially methylated genes as diagnostic and prognostic biomarkers of breast cancer

Identifying Methylation Pattern And Genes Associated With Breast Cancer Subtypes

Screening of Breast Cancer Methylation Biomarkers Based on the TCGA Database

Detection of Aberrantly Methylated Tumor Suppressor Genes in Breast Cancer Patients As a Potential Diagnostic Biomarker

Microarray-based analysis of whole-genome DNA methylation profiling in early detection of breast cancer.

Aberrant Promoter Methylation of Cancer-Related Genes in Human Breast Cancer

A Novel Gene Prognostic Signature Based on Differential DNA Methylation in Breast Cancer.